8,000
Participants
Start Date
January 31, 2004
Primary Completion Date
December 31, 2020
Study Completion Date
December 31, 2020
Capecitabine and Oxaliplatin
Capecitabine and Oxaliplatin will be under the NSCLC guideline
RECRUITING
State Key Laboratory of Cancer Biology, Xi'an
Collaborators (1)
Tianjin Union Medical Center
OTHER
Beihua University
OTHER
Chengdu Medical College
OTHER
Shanghai Jiao Tong University School of Medicine
OTHER
State Key Laboratory of Cancer Biology
NETWORK